Antibiotic shows promise in controlling rare eye cancer
NCT ID NCT01820910
First seen Jan 27, 2026 · Last updated Apr 30, 2026 · Updated 15 times
Summary
This study tested whether a long course of the antibiotic doxycycline could control a rare type of eye lymphoma (OAMZL) linked to a bacterial infection. 44 newly diagnosed patients received the antibiotic, and doctors monitored for infection return, retreating if needed. The goal was to see how long the cancer stayed under control without standard chemotherapy or radiation.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MARGINAL ZONE LYMPHOMA OF OCULAR ADNEXAL are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
AO Ospedali Riuniti Papardo Piemonte
Messina, Italy
-
Ematologia
Parma, Italy
-
Molinette 1
Torino, Italy
-
Ospedale Civile
Piacenza, Italy
-
Ospedale San Raffaele
Milan, Italy
-
Ospedale dell'Angelo
Venezia, Italy
-
Spedali Civili Di Brescia
Brescia, Italy
-
Università La Sapienza
Rome, Italy
Conditions
Explore the condition pages connected to this study.